Nitrolingual



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 42.9%
Chest Pain 28.6%
Angina Pectoris 14.3%
Drug Use For Unknown Indication 14.3%
Device Failure 14.3%
Drug Ineffective 14.3%
Hypertension 14.3%
Malaise 14.3%
Postpartum Haemorrhage 14.3%
Product Quality Issue 14.3%
Unresponsive To Stimuli 14.3%
Secondary
Diabetes Mellitus 11.0%
Hypersensitivity 9.7%
Asthma 8.7%
Hypertension 7.6%
Drug Use For Unknown Indication 7.2%
Gastrooesophageal Reflux Disease 6.6%
Chronic Obstructive Pulmonary Disease 5.1%
Chest Pain 4.2%
Depression 4.2%
Migraine 4.2%
Arthralgia 3.8%
Diabetic Neuropathy 3.8%
Anxiety 3.6%
Muscle Spasms 3.6%
Pain 3.6%
Fluid Retention 3.0%
Hypertensive Crisis 2.5%
Parenteral Nutrition 2.5%
Product Used For Unknown Indication 2.5%
Pyrexia 2.5%
Memory Impairment 34.0%
Mesothelioma 17.0%
Toxic Epidermal Necrolysis 12.8%
Myocardial Infarction 10.6%
Panic Attack 6.4%
Muscle Spasms 4.3%
Pulmonary Embolism 4.3%
Ventricular Fibrillation 4.3%
Nasopharyngitis 2.1%
Small Cell Lung Cancer Stage Unspecified 2.1%
Urinary Tract Infection 2.1%
Concomitant
Product Used For Unknown Indication 31.8%
Drug Use For Unknown Indication 21.2%
Hypertension 9.9%
Angina Pectoris 5.2%
Coronary Artery Disease 4.2%
Pain 4.0%
Cardiac Disorder 3.5%
Chest Pain 2.5%
Atrial Fibrillation 2.0%
Diabetes Mellitus 2.0%
Asthma 1.8%
Diagnostic Procedure 1.6%
Myocardial Infarction 1.6%
Rheumatoid Arthritis 1.4%
Anticoagulant Therapy 1.3%
Depression 1.3%
Cardiac Failure Congestive 1.2%
Cerebrovascular Accident Prophylaxis 1.2%
Blood Cholesterol Increased 1.1%
Memory Impairment 1.1%
Myocardial Infarction 13.1%
Vomiting 10.7%
Weight Decreased 6.5%
Hyperkalaemia 6.0%
Hypertensive Crisis 5.4%
Pain 5.4%
Death 4.8%
Pneumonia 4.8%
Angina Pectoris 4.2%
Chest Pain 4.2%
Dyspnoea 4.2%
Pulmonary Embolism 4.2%
Respiratory Moniliasis 4.2%
Hypotension 3.6%
Syncope 3.6%
Urinary Tract Infection 3.6%
Cerebrovascular Accident 3.0%
Circulatory Collapse 3.0%
Hyponatraemia 3.0%
Paralysis 3.0%